1.Experimental Study of Inhibiting Effect of YIGSR Derivants on Metastasis of Melanoma B16 to Lung
Tihua ZHAO ; Wei GAO ; Hesong YANG ; Yafeng CHEN ; Yanhua SHI ; Shuhua DENG
China Pharmacy 2001;12(3):144-145
OBJECTIVE: To study the anti- metastatic action of equal/unequal- fork- peptide of YIGSR.METHODS: To observe the influence of drugs on metastasis of melanoma B16 to lung in mice.RESULTS: The metastatic rate of lung in 46 mice of control and experimental groups was 100% ,21 days after inoculating melanoma B16 cells via caudal vein.Injection of YIGSR in combination with tumor cells could reduce the number of metastatic nodules in a dose- dependent manner.The numbers of metastatic nodules in 100μ g~ 200μ g equal fork peptide group and same dosage unequal fork peptide group were significantly different from that in control group(P<0.05;P<0.01 respectively).50μ g equal fork peptide group was different from control group.The synthetic peptide could not decrease the weight of the lung with metastatic lesions.CONCLUSION: YIGSR derivants have effective antimetastatic actions.Its mechanism may related to the inhibiting effect on formation of cancer cell emboli,which retain in microvessels of remote target organs,and multiplicate and penetrate blood vessels to form micrometastatic lesions.
2.Correlation of osteopontin expression and laryngeal squamous cell carcinoma infiltration and metastasis.
ZHAO HONGCHUN ; WANG YANFEI ; ZHENG TIHUA ; CHE JUAN ; CAO RUIJUAN ; WANG XIA
Journal of Clinical Otorhinolaryngology Head and Neck Surgery 2015;29(17):1530-1533
OBJECTIVE:
To investigate osteopontin (OPN) expression in plasma and tissue of patients with layngeal squamous cell carcinoma and analyze its role in invasion, metastasis, and clinical significance in laryngeal quamous cell carcinoma.
METHOD:
Enzyme-linked immunosorbent assay (ELISA) and immunohistochemistry were used to detect expression of OPN in plasma and tissue of 60 cases of laryngeal squamous cell carcinoma, 20 cases of adjacent normal laryngeal tissue and 20 cases of plasma from healthy subjects.
RESULT:
The expression of plasma OPN was closely correlated with clinical stage and cervical lymphatic metastasis in laryngeal squamous cell carcinoma (P < 0.05), but no significant correlation with the tumor location, pathological grade, gender and age (P > 0.05). The expression of OPN increased in plasma during cancer development: laryngeal squamous cell carcinoma (38.089 ± 9.225) ng/ml, healthy subjects (18.563 ± 9.308) ng/ml. There was a significant difference between the groups (P < 0.05). The expression of OPN in tissue was closely correlated with clinical stage (P < 0.05), pathological grade (P < 0.05) and cervical lymphatic metastasis (P < 0.05) in laryngeal squamous cell carcinoma adjacent atypical hyperplastic epithelium and carcinoma. The expression of OPN increased in tissue during cancer development: laryngeal squamous cell carcinoma (56.67%), adjacent normal laryngeal tissue (15.00%). There was a significant difference between the groups (P < 0.05). Elevated expression of plasma OPN is positively correlated with the expression of OPN in tissue in laryngeal squamous cell carcinoma patients (r = 0. 871, P < 0.05).
CONCLUSION
OPN plays an important role in the infiltration, metastasis and carcinogenesis in laryngeal squamous cell carcinoma. Combination of serum OPN, tissue OPN detection can be used as diagnostic and surveillance indicators for laryngeal squamous cell carcinoma infiltration and metastasis.
Carcinoma, Squamous Cell
;
metabolism
;
pathology
;
Case-Control Studies
;
Enzyme-Linked Immunosorbent Assay
;
Head and Neck Neoplasms
;
metabolism
;
pathology
;
Humans
;
Hyperplasia
;
pathology
;
Immunohistochemistry
;
Laryngeal Neoplasms
;
metabolism
;
pathology
;
Larynx
;
pathology
;
Lymphatic Metastasis
;
Neck
;
Osteopontin
;
metabolism
;
Squamous Cell Carcinoma of Head and Neck